PLoS ONE · 2014 · 64 citations · 38 references
Veterinary MedicineMolecular GeneticsPharmacologyHepatotoxicologyPharmacogeneticsPharmacogenomicsBiomarkers Of Liver InjuryHepatic ImpairmentHepatic ToxicityHepatotoxicity MechanismsLiver DiseaseLiver Function TestsDrug Metabolism PolymorphismsDrug-metabolizing Enzyme VariabilityGenetic PolymorphismsGenetic Risk MarkersHepatotoxic MechanismsMetabolism Enzyme PolymorphismsPcr-based DetectionRisk Factors For Hepatotoxicity
BACKGROUND AND OBJECTIVE: Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms in these enzymes were associated with an increased risk of anti-TB drug-induced hepatitis in patients and could potentially be used to identify patients at risk of liver injury. METHODS AND DESIGN: In a cross-sectional study, 2244 tuberculosis patients were assessed two months after the start of treatment. Anti-TB drug-induced liver injury (ATLI) was defined as an ALT, AST or bilirubin value more than twice the upper limit of normal. NAT2, CYP2E1, GSTM1 and GSTT1 genotypes were determined using the PCR/ligase detection reaction assays. RESULTS: 2244 patients were evaluated, there were 89 cases of ATLI, a prevalence of 4% 9 patients (0.4%) had ALT levels more than 5 times the upper limit of normal. The prevalence of ATLI was greater among men than women, and there was a weak association with NAT2*5 genotypes, with ATLI more common among patients with the NAT2*5*CT genotype. The sensitivity of the CT genotype for identifying patients with ATLI was 42% and the positive predictive value 5.9%. CT ATLI was more common among slow acetylators (prevalence ratio 2.0 (95% CI 0.95,4.20) )compared to rapid acetylators. There was no evidence that ATLI was associated with CYP2E1 RsaIc1/c1genotype, CYP2E1 RsaIc1/c2 or c2/c2 genotypes, or GSTM1/GSTT1 null genotypes. CONCLUSIONS: In Xinjiang Uyghur TB patients, liver injury was associated with the genetic variant NAT2*5, however the genetic markers studied are unlikely to be useful for screening patients due to the low sensitivity and low positive predictive values for identifying persons at risk of liver injury.
38
Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 841 citations
Theta, a new class of glutathione transferases purified from rat and man
David J. Meyer, B Coles, Sally Pemble et al. · Biochemical Journal · 1991 · 737 citations · Full text
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Yi‐Shin Huang, Herng‐Der Chern, Wei‐Juin Su et al. · Hepatology · 2003 · 427 citations · Full text
Medicine, Pharmacology, Toxicology +15
Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 335 citations